CTRI/2019/06/019786
Not yet recruiting
Phase 2
A Comparative Clinical Study on the efficacy of Vaaluka Svedana followed by Kati-pristha-trikabasti with or without Erandamooladi Yogabasti in the management of Kati-Pristha-Trika Graha w.s.r. to Ankylosing Spondylitis.
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: M450- Ankylosing spondylitis of multiplesites in spine
- Sponsor
- All India Institute of Ayurveda
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1 Duration of the disease: 1yr to 10 years
- •2 Socio\- economic status: All
- •3 Diagnosed cases of Ankylosing Spondylitis
Exclusion Criteria
- •1 Chronicity of disease more than 10 yrs.
- •2 Severely deformed joints.
- •3 Cardiac disease, pulmonary tuberculosis,
- •severe lung disease and pregnant women.
- •4 Patients unfit for Snehana,Svedana and Basti
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Ayurvedic management of diabetesHealth Condition 1: E139- Other specified diabetes mellituswithout complicationsHealth Condition 2: E119- Type 2 diabetes mellitus without complicationsCTRI/2019/03/017952All India Institute of Ayurveda
Completed
Phase 2
A clinical trial to study the effects of Vamana karma and Maricha choorna in the patients of sheetapitta (Urticaria).Health Condition 1: L509- Urticaria, unspecifiedCTRI/2021/01/030495All India Institute of Ayurveda30
Not yet recruiting
Phase 1
Panchakarma, Ayurveda, Emesis, Powder massage, hypothyroidismHealth Condition 1: - Health Condition 2: E02- Subclinical iodine-deficiency hypothyroidismCTRI/2020/01/022809Dr Mallika Singh
Not yet recruiting
Phase 3
Comparison of Ash gourd consumption orally and Kunjal Kriya in reducing the symptoms of Acidity.Health Condition 1: K20-K31- Diseases of esophagus, stomach and duodenumCTRI/2024/05/067115Ch.Brahm Prakash Ayurved Charak Sansthan
Active, not recruiting
Phase 1
Comparison of effectiveness and safety of vaginally used Dequalinium Chloride with orally taken Metronidazole in the treatment of bacterial vaginosisEUCTR2020-002489-15-SKMedinova AG236